Article on AYTU, mentions the Suda for the potential revenue opportunity from Zolpimist sales.https://seekingalpha.com/instablog/49294679-soulstring-report/5285947-aytu-bioscience-aytu-building-another-arbor-pharmaceuticals-investors-say-yes
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game